As a new anti-Parkinson's disease drug, safenamide provides new treatment options for patients with Parkinson's disease through its unique dual mechanism of action.

iPSC technology has both the totality of cell differentiation and its own infinite replication ability, providing cure possibilities for many untreatable diseases.

Stem cell-based therapies have become a promising treatment that leverages the regenerative potential of stem cells to repair damaged neural tissue and neural circuits for the treatment of various nervous system diseases.

As the origin cells of the human body, stem cells have unique effects that have not been seen in traditional medicines in improving sub-health status, preventing and treating chronic diseases, and beautifying and resisting aging.

This time, the research team of Union Medical College Hospital has innovatively used stem cell nasal mucosal administration to treat PD, which has left a strong mark in the field of treatment of Parkinson's disease!

Induced pluripotent stem cells (iPS cells) are regarded as the "universal cells" of regenerative medicine because of their functions such as infinite proliferation and multi-directional differentiation potential.

Mesenchymal stem cells (MSCs) have attracted much attention in regenerative medicine and tissue engineering due to their pluripotency, self-renewal ability and low immunogenicity.

The Japanese government has included some reviewed regenerative medical products in medical insurance reimbursement.